4 not yet recruiting. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Not yet recruiting 4 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Organoid Drug Sensitivity Testing-Guided Therapy: new trials by email Literature Review of Organoid Drug Sensitivity Testing-Guided Therapy trials Research Report on Organoid Drug Sensitivity Testing-Guided Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Hepatocellular Carcinoma Organoid Drug Sensitivity Testing-Guided Therapy - Unresectable Hepatocellular Carcinoma | Phase 2 | Not yet recruiting | Eastern Hepatobiliary Surgery Hospital | 94 | 2026-01-30 | 2026-01-20 |
| Drug Sensitivity Testing-Based Tumor Organoids to Guide Adjuvant Therapy After Hepatectomy for Primary Liver Cancer Organoid Drug Sensitivity Testing-Guided Therapy - Hepatocellular Carcinoma Resectable | Phase 2 | Not yet recruiting | Eastern Hepatobiliary Surgery Hospital | 56 | 2026-01-30 | 2026-01-23 |
| A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Biliary Tract Cancers Organoid Drug Sensitivity Testing-Guided Therapy - Advanced Biliary Tract Cancer(BTC) | Phase 2 | Not yet recruiting | Eastern Hepatobiliary Surgery Hospital | 88 | 2026-01-30 | 2026-01-20 |
| Organoid-guided vs Topotecan Therapy in Relapsed Extensive-Stage Small Cell Lung Cancer Organoid Drug Sensitivity Testing-Guided Therapy, Topotecan - Extensive-stage Small Cell Lung Cancer (ES-SCLC), Extensive-stage Small Cell Lung Cancer (SCLC) | Phase 2 / Phase 3 | Not yet recruiting | Peking Union Medical College Hospital | 128 | 2025-08-01 | 2025-08-06 |
Eastern Hepatobiliary Surgery Hospital (3) · Peking Union Medical College Hospital (1)
China (1)
Feng Shen (3)